Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial-mesenchymal transition in prostate cancer

Nutritional starvation (NST) is the basis of tumor anti-angiogenesis and metabolic therapy strategy. Silencing Akt1 inhibits prostate cancer (PCa) cells growing; slow-growing cells tend to consume less nutrition. It is suggested that Akt1-silenced cancer cells will have a more substantial tolerance to NST. Clarify this critical question is vital for tumor treatment strategies based on Akt1 and NST. The Akt1 gene of PC3 and DU145 cells was silenced by lent-virus. NST model was established by serum stripping. Cell viability was detected by MTT assay and cell counting method. Apoptosis was detected by TUNEL and flow cytometry, and cell invasion was determined by transwells and ECIS. The markers of epithelial-mesenchymal transition (EMT) were detected by western blotting. PCa lung metastasis model was established by tail vein injection and quantified by Indian ink and GFP fluorescence. Silencing Akt1 slowed down the decrease of cell number and increase of apoptosis caused by NST. Silencing Akt1 with NST exposure in PCa cells could down-regulate epithelial markers (E-cadherin, claudin-5, and ZO-1) and up-regulate mesenchymal markers N-cadherin and EMT regulators Snail. Although silencing Akt1 enhanced the invasion of PCa cells induced by NST in vitro, silencing Akt1 inhibited the PCa lung metastasis induced by NST in vivo. Silencing Akt1 gene enhances the resistance of PCa cells to NST. The invasion results in vitro were inconsistent with those metastases in vivo, which may be related to a combination of NST with silencing Akt1 to maintain the mesenchymal state of PCa cells through EMT.

Automated summary

This study investigates the effects of Akt1 and nutritional starvation (NST) on prostate cancer cells. The results show that silencing Akt1 enhances the resistance of cells to NST and maintains the mesenchymal state of cells through changes in epithelial-mesenchymal transition markers. Additionally, in vivo experiments demonstrate that silencing Akt1 inhibits lung metastasis formation.